Spontaneous Evisceration of Infantile Umbilical Hernia

Sponsor
Ahmed Kamel Ali Mohamed (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05852535
Collaborator
(none)
1
1
17
1.8

Study Details

Study Description

Brief Summary

Infantile umbilical hernia is common in children. It has a regressive course in most cases. Conservative management is the standard in most cases before the age of 3 years unless there are complications such as incarceration, rupture with evisceration which are extremely rare and warrants emergency surgery.

We present a rare case of a 6-month-old child with sudden spontaneous evisceration of infantile umbilical hernia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Exploration

Detailed Description

Infantile umbilical hernia is common in children. It has a regressive course in most cases. Conservative management is the standard in most cases before the age of 3 years unless there are complications such as incarceration, rupture with evisceration which are extremely rare and warrants emergency surgery.

We present a rare case of a 6-month-old child with sudden spontaneous evisceration of infantile umbilical hernia.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Spontaneous Evisceration of Infantile Umbilical Hernia
Anticipated Study Start Date :
May 7, 2023
Anticipated Primary Completion Date :
May 23, 2023
Anticipated Study Completion Date :
May 24, 2023

Arms and Interventions

Arm Intervention/Treatment
case report

Procedure: Exploration
abdominal exploration

Outcome Measures

Primary Outcome Measures

  1. hospital stay [From April 1, 2023 to April 1, 2024]

    hospital stay

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 3 Years
Sexes Eligible for Study:
Male
Inclusion Criteria:
  • Pediatric group
Exclusion Criteria:
  • Adult group

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ahmed Ali Assiut Egypt 71111

Sponsors and Collaborators

  • Ahmed Kamel Ali Mohamed

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ahmed Kamel Ali Mohamed, Mr., Assiut University
ClinicalTrials.gov Identifier:
NCT05852535
Other Study ID Numbers:
  • AKA171292
First Posted:
May 10, 2023
Last Update Posted:
May 10, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 10, 2023